{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:01:46Z","timestamp":1792123306476,"version":"4.4.0"},"reference-count":229,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01-HL093052"],"award-info":[{"award-number":["R01-HL093052"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["PO1-HL034300"],"award-info":[{"award-number":["PO1-HL034300"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1RO1-HL139793"],"award-info":[{"award-number":["1RO1-HL139793"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.pharmthera.2018.07.004","type":"journal-article","created":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T17:38:27Z","timestamp":1532367507000},"page":"74-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":113,"special_numbering":"C","title":["20-HETE in the regulation of vascular and cardiac function"],"prefix":"10.1016","volume":"192","author":[{"given":"Petra","family":"Rocic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal Laniado","family":"Schwartzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2018.07.004_bb0005","doi-asserted-by":"crossref","first-page":"F662","DOI":"10.1152\/ajprenal.00146.2009","article-title":"20-HETE activates the Raf\/MEK\/ERK pathway in renal epithelial cells through an EGFR- and c-Src-dependent mechanism","volume":"297","author":"Akbulut","year":"2009","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0010","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1161\/01.STR.30.12.2727","article-title":"Contribution of 20-HETE to vasodilator actions of nitric oxide in the cerebral microcirculation","volume":"30","author":"Alonso-Galicia","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0015","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1152\/ajpregu.00664.2001","article-title":"Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II","volume":"283","author":"Alonso-Galicia","year":"2002","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0020","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/03602532.2012.754460","article-title":"Role of cytochrome P450-mediated arachidonic acid metabolites in the pathogenesis of cardiac hypertrophy","volume":"45","author":"Alsaad","year":"2013","journal-title":"Drug Metabolism Reviews"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0025","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1124\/dmd.115.063776","article-title":"Early changes in cytochrome P450s and their associated arachidonic acid metabolites play a crucial role in the initiation of cardiac hypertrophy induced by isoproterenol","volume":"43","author":"Althurwi","year":"2015","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0030","doi-asserted-by":"crossref","first-page":"H1528","DOI":"10.1152\/ajpheart.00406.2002","article-title":"CYP4A metabolites of arachidonic acid and VEGF are mediators of skeletal muscle angiogenesis","volume":"284","author":"Amaral","year":"2003","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0035","first-page":"294","article-title":"20-Hydroxyeicosatetraenoic acid induces apoptosis in neonatal rat cardiomyocytes through mitochondrial-dependent pathways","volume":"57","author":"Bao","year":"2011","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0040","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.freeradbiomed.2007.03.004","article-title":"A reduction in alcohol consumption is associated with reduced plasma F(2)-isoprostanes and urinary 20-HETE excretion in men","volume":"42","author":"Barden","year":"2007","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0045","doi-asserted-by":"crossref","first-page":"31709","DOI":"10.1074\/jbc.M304437200","article-title":"20-hydroxyeicosatetraenoic acid (20-HETE) activates mouse TRPC6 channels expressed in HEK293 cells","volume":"278","author":"Basora","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0050","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0028-3908(02)00047-3","article-title":"Vanilloid and TRP channels: a family of lipid-gated cation channels","volume":"42","author":"Benham","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0055","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1474-8673.2005.00343.x","article-title":"Contribution of cytochrome P450 metabolites of arachidonic acid to hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME","volume":"25","author":"Benter","year":"2005","journal-title":"Autonomic & Autacoid Pharmacology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0060","doi-asserted-by":"crossref","first-page":"L564","DOI":"10.1152\/ajplung.00298.2009","article-title":"20-HETE-induced nitric oxide production in pulmonary artery endothelial cells is mediated by NADPH oxidase, H2O2, and PI3-kinase\/Akt","volume":"298","author":"Bodiga","year":"2010","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0065","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1161\/hy0202.103420","article-title":"Regulation of cyclooxygenase- and cytochrome p450-derived eicosanoids by heme oxygenase in the rat kidney","volume":"39","author":"Botros","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0070","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009191","article-title":"Insulin receptor signaling in normal and insulin-resistant states","volume":"6","author":"Boucher","year":"2014","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0075","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1161\/HYPERTENSIONAHA.111.00942","article-title":"Activation of neuronal transient receptor potential vanilloid 1 channel underlies 20-hydroxyeicosatetraenoic acid-induced vasoactivity: role for protein kinase A","volume":"62","author":"Bubb","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0080","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1096\/fasebj.6.2.1537463","article-title":"Cytochrome P450 and the arachidonate cascade","volume":"6","author":"Capdevila","year":"1992","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0085","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0022-2275(20)32049-6","article-title":"Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase","volume":"41","author":"Capdevila","year":"2000","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0090","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/ki.1997.234","article-title":"Cytochrome P450-derived renal HETEs: storage and release","volume":"51","author":"Carroll","year":"1997","journal-title":"Kidney International"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.prostaglandins.2011.12.005","article-title":"20-HETE in neovascularization","volume":"98","author":"Chen","year":"2012","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0100","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1124\/jpet.113.210120","article-title":"20-HETE regulates the angiogenic functions of human endothelial progenitor cells and contributes to angiogenesis in vivo","volume":"348","author":"Chen","year":"2014","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.vph.2016.04.002","article-title":"20-HETE contributes to ischemia-induced angiogenesis","volume":"83","author":"Chen","year":"2016","journal-title":"Vascular Pharmacology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0110","doi-asserted-by":"crossref","first-page":"L369","DOI":"10.1152\/ajplung.00424.2005","article-title":"Mechanisms of activation of eNOS by 20-hydroxyeicosatetraenoic acid and VEGF in bovine pulmonary artery endothelial cells","volume":"291","author":"Chen","year":"2006","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0115","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1096\/fj.13-241927","article-title":"Vascular characterization of mice with endothelial expression of cytochrome P450 4F2","volume":"28","author":"Cheng","year":"2014","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0120","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1161\/ATVBAHA.112.248344","article-title":"Induction of angiotensin-converting enzyme and activation of the renin-angiotensin system contribute to 20-hydroxyeicosatetraenoic acid-mediated endothelial dysfunction","volume":"32","author":"Cheng","year":"2012","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0125","doi-asserted-by":"crossref","first-page":"H1018","DOI":"10.1152\/ajpheart.01172.2007","article-title":"20-Hydroxyeicosatetraenoic acid causes endothelial dysfunction via eNOS uncoupling","volume":"294","author":"Cheng","year":"2008","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1124\/jpet.109.159863","article-title":"20-hydroxy-5,8,11,14-eicosatetraenoic acid mediates endothelial dysfunction via IkappaB kinase-dependent endothelial nitric-oxide synthase uncoupling","volume":"332","author":"Cheng","year":"2010","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0135","doi-asserted-by":"crossref","first-page":"38166","DOI":"10.1074\/jbc.M104818200","article-title":"Alternative splicing determines the function of CYP4F3 by switching substrate specificity","volume":"276","author":"Christmas","year":"2001","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0140","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3389\/fphys.2018.00490","article-title":"Detrimental effects of testosterone addition to estrogen therapy involve cytochrome P-450-Induced 20-HETE synthesis in aorta of ovariectomized spontaneously hypertensive rat (SHR), a model of postmenopausal hypertension","volume":"9","author":"Costa","year":"2018","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0145","doi-asserted-by":"crossref","first-page":"F544","DOI":"10.1152\/ajprenal.2000.279.3.F544","article-title":"Angiotensin II releases 20-HETE from rat renal microvessels","volume":"279","author":"Croft","year":"2000","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0150","doi-asserted-by":"crossref","first-page":"F71","DOI":"10.1152\/ajprenal.00458.2015","article-title":"20-HETE and CYP4A2 omega-hydroxylase contribute to the elevated blood pressure in hyperandrogenemic female rats","volume":"311","author":"Dalmasso","year":"2016","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0155","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00000441-199403000-00003","article-title":"Tin mediated heme oxygenase gene activation and cytochrome P450 arachidonate hydroxylase inhibition in spontaneously hypertensive rats","volume":"70","author":"DaSilva","year":"1994","journal-title":"Am.J.Med.Sci."},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0160","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.pnpbp.2010.03.009","article-title":"CYP4F2 gene V433M polymorphism is associated with ischemic stroke in the male Northern Chinese Han population","volume":"34","author":"Deng","year":"2010","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0165","doi-asserted-by":"crossref","first-page":"H777","DOI":"10.1152\/ajpheart.01087.2008","article-title":"20-HETE increases survival and decreases apoptosis in pulmonary arteries and pulmonary artery endothelial cells","volume":"296","author":"Dhanasekaran","year":"2009","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0170","doi-asserted-by":"crossref","first-page":"F753","DOI":"10.1152\/ajprenal.00292.2013","article-title":"20-HETE induces remodeling of renal resistance arteries independent of blood pressure elevation in hypertension","volume":"305","author":"Ding","year":"2013","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0175","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1006\/jmcc.2000.1352","article-title":"Mitochondrial K(ATP)channel opening during index ischemia and following myocardial reperfusion in ischemic rat hearts","volume":"33","author":"Downey","year":"2001","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0180","doi-asserted-by":"crossref","first-page":"H2455","DOI":"10.1152\/ajpheart.00512.2008","article-title":"Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats","volume":"295","author":"Dunn","year":"2008","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0185","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.2174\/15680266113139990110","article-title":"CYP4 enzymes as potential drug targets: focus on enzyme multiplicity, inducers and inhibitors, and therapeutic modulation of 20-hydroxyeicosatetraenoic acid (20-HETE) synthase and fatty acid omega-hydroxylase activities","volume":"13","author":"Edson","year":"2013","journal-title":"Current Topics in Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0190","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.taap.2015.10.003","article-title":"19-Hydroxyeicosatetraenoic acid and isoniazid protect against angiotensin II-induced cardiac hypertrophy","volume":"289","author":"Elkhatali","year":"2015","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0195","doi-asserted-by":"crossref","first-page":"C1775","DOI":"10.1152\/ajpcell.1994.266.6.C1775","article-title":"Cytochrome P450 arachidonate metabolites affect ion fluxes in rabbit medullary thick ascending limb","volume":"266","author":"Escalante","year":"1994","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(93)90812-V","article-title":"20-hydroxyeicosatetraenoic acid is an endothelium-dependent vasoconstrictor in rabbit arteries","volume":"235","author":"Escalante","year":"1993","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0205","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/01.HYP.17.6.776","article-title":"Chronic treatment with tin normalizes blood pressure in spontaneoulsy hypertensive rats","volume":"17","author":"Escalante","year":"1991","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0210","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2741\/4465","article-title":"Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology","volume":"21","author":"Fan","year":"2016","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0215","doi-asserted-by":"crossref","first-page":"R379","DOI":"10.1152\/ajpregu.00256.2014","article-title":"Impaired myogenic response and autoregulation of cerebral blood flow is rescued in CYP4A1 transgenic Dahl salt-sensitive rat","volume":"308","author":"Fan","year":"2015","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0220","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1161\/HYPERTENSIONAHA.108.114199","article-title":"The V433M variant of the CYP4F2 is associated with ischemic stroke in male Swedes beyond its effect on blood pressure","volume":"52","author":"Fava","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0225","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.prostaglandins.2011.11.007","article-title":"Hypertension, cardiovascular risk and polymorphisms in genes controlling the cytochrome P450 pathway of arachidonic acid: A sex-specific relation?","volume":"98","author":"Fava","year":"2012","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0230","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ddmec.2007.12.006","article-title":"Mechanisms of post-infarct left ventricular remodeling","volume":"4","author":"French","year":"2007","journal-title":"Drug Discovery Today Dis Mech"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0235","doi-asserted-by":"crossref","first-page":"H1517","DOI":"10.1152\/ajpheart.2000.278.5.H1517","article-title":"Contribution of cytochrome P-450 omega-hydroxylase to altered arteriolar reactivity with high-salt diet and hypertension","volume":"278","author":"Frisbee","year":"2000","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0240","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/1076029611436197","article-title":"A novel polymorphism of the CYP4A11 gene is associated with coronary artery disease","volume":"19","author":"Fu","year":"2013","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0245","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/ajh.2008.276","article-title":"A haplotype of the CYP4F2 gene is associated with cerebral infarction in Japanese men","volume":"21","author":"Fu","year":"2008","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0250","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1601-5223.2012.02247.x","article-title":"Haplotype-based case-control study of CYP4A11 gene and myocardial infarction","volume":"149","author":"Fu","year":"2012","journal-title":"Hereditas"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0255","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ymgme.2008.11.161","article-title":"A haplotype of the CYP4F2 gene associated with myocardial infarction in Japanese men","volume":"96","author":"Fu","year":"2009","journal-title":"Molecular Genetics and Metabolism"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0260","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.gene.2012.10.007","article-title":"Haplotype study of the CYP4A11 gene and coronary artery disease in Han and Uygur populations in China","volume":"512","author":"Fu","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0265","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/01.CIR.0000151309.82473.59","article-title":"Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension","volume":"111","author":"Gainer","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0270","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1681\/ASN.2008010063","article-title":"Association of a CYP4A11 variant and blood pressure in black men","volume":"19","author":"Gainer","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0275","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1128\/MCB.00138-16","article-title":"Hepatic overexpression of CD36 improves glycogen homeostasis and attenuates high-fat diet-induced hepatic steatosis and insulin resistance","volume":"36","author":"Garbacz","year":"2016","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0280","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.prostaglandins.2014.12.001","article-title":"Androgen-induced hypertension in angiotensinogen deficient mice: role of 20-HETE and EETS","volume":"116-117","author":"Garcia","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0285","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/CIRCRESAHA.116.310525","article-title":"20-HETE signals through G-protein-coupled receptor GPR75 (Gq) to affect vascular function and trigger hypertension","volume":"120","author":"Garcia","year":"2017","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0290","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1152\/ajpregu.00039.2015","article-title":"Angiotensin II receptor blockade or deletion of vascular endothelial ACE does not prevent vascular dysfunction and remodeling in 20-HETE-dependent hypertension","volume":"309","author":"Garcia","year":"2015","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0295","first-page":"74","article-title":"Recent developments on the vascular effects of 20-hydroxyeicosatetraenoic acid","volume":"26","author":"Garcia","year":"2017","journal-title":"Current Opinion in Nephrology and Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0300","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1124\/jpet.115.229377","article-title":"20-HETE activates the transcription of angiotensin-converting enzyme via nuclear factor-kappaB translocation and promoter binding","volume":"356","author":"Garcia","year":"2016","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0305","doi-asserted-by":"crossref","first-page":"F509","DOI":"10.1152\/ajprenal.00273.2014","article-title":"Role of 20-HETE in the impaired myogenic and TGF responses of the Af-Art of Dahl salt-sensitive rats","volume":"307","author":"Ge","year":"2014","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0310","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1161\/01.RES.87.1.60","article-title":"Production of 20-HETE and its role in autoregulation of cerebral blood flow","volume":"87","author":"Gebremedhin","year":"2000","journal-title":"Circulation Research"},{"issue":"Pt 3","key":"10.1016\/j.pharmthera.2018.07.004_bb0315","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1469-7793.1998.771bs.x","article-title":"Cat cerebral arterial smooth muscle cells express cytochrome P450 4A2 enzyme and produce the vasoconstrictor 20-HETE which enhances L-type Ca2+ current","volume":"507","author":"Gebremedhin","year":"1998","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0320","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000158975","article-title":"Role of cytochrome P-450 in elevating renal vascular tone in spontaneously hypertensive rats","volume":"30","author":"Gebremedhin","year":"1993","journal-title":"Journal of Vascular Research"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0325","doi-asserted-by":"crossref","first-page":"H107","DOI":"10.1152\/ajpheart.01416.2006","article-title":"Role of 20-HETE in the hypoxia-induced activation of Ca2+-activated K+ channel currents in rat cerebral arterial muscle cells","volume":"294","author":"Gebremedhin","year":"2008","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0330","first-page":"1245","article-title":"Cytochrome P450 omega-hydroxylase inhibition reduces infarct size during reperfusion via the sarcolemmal KATP channel","volume":"37","author":"Gross","year":"2004","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0335","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1124\/jpet.106.115360","article-title":"Activation of vascular endothelial growth factor through reactive oxygen species mediates 20-hydroxyeicosatetraenoic acid-induced endothelial cell proliferation","volume":"321","author":"Guo","year":"2007","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0340","doi-asserted-by":"crossref","first-page":"H602","DOI":"10.1152\/ajpheart.00874.2008","article-title":"20-HETE can act as a nonhypoxic regulator of HIF-1alpha in human microvascular endothelial cells","volume":"297","author":"Guo","year":"2009","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0345","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1253\/circj.CJ-12-1211","article-title":"20-Hydroxyeicosatetraenoic acid mediates isolated heart ischemia\/reperfusion injury by increasing NADPH oxidase-derived reactive oxygen species production","volume":"77","author":"Han","year":"2013","journal-title":"Circulation Journal"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0350","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000159080","article-title":"Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone","volume":"32","author":"Harder","year":"1995","journal-title":"Journal of Vascular Research"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0355","first-page":"H2098","article-title":"Formation and action of a P-450 4A metabolite of arachidonic acid in cat cerebral microvessels","volume":"266","author":"Harder","year":"1994","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0360","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/01.RES.79.1.54","article-title":"Identification of a putative microvascular oxygen sensor","volume":"79","author":"Harder","year":"1996","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0365","doi-asserted-by":"crossref","first-page":"H1557","DOI":"10.1152\/ajpheart.01097.2010","article-title":"Pressure-induced myogenic tone and role of 20-HETE in mediating autoregulation of cerebral blood flow","volume":"300","author":"Harder","year":"2011","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0370","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.bcp.2008.03.004","article-title":"Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases","volume":"75","author":"Hardwick","year":"2008","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0375","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/B978-0-12-404717-4.00005-6","article-title":"Eicosanoids in metabolic syndrome","volume":"66","author":"Hardwick","year":"2013","journal-title":"Advances in Pharmacology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0380","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0022-3565(24)35401-1","article-title":"Cytochrome P450 omega\/omega-1 hydroxylase-derived eicosanoids contribute to endothelin(A) and endothelin(B) receptor-mediated vasoconstriction to endothelin-1 in the rat preglomerular arteriole","volume":"292","author":"Hercule","year":"2000","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0385","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1113\/jphysiol.2003.049981","article-title":"Contribution of cytochrome P450 4A isoforms to renal functional response to inhibition of nitric oxide production in the rat","volume":"551","author":"Hercule","year":"2003","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0390","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/bms.1200210505","article-title":"Quantitation of 20-hydroxy-5,8,11,14-eicosatetraenoic acid (20-HETE) produced by human polymorphonuclear leukocytes using electron capture ionization gas chromatography\/mass spectrometry","volume":"21","author":"Hill","year":"1992","journal-title":"Biological Mass Spectrometry"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0395","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1161\/01.HYP.0000120123.44945.47","article-title":"Elevated BSC-1 and ROMK expression in Dahl salt-sensitive rat kidneys","volume":"43","author":"Hoagland","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0400","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/01.HYP.0000047881.15426.DC","article-title":"Contributions of 20-HETE to the antihypertensive effects of Tempol in Dahl salt-sensitive rats","volume":"41","author":"Hoagland","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0405","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1073\/pnas.081627898","article-title":"Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension","volume":"98","author":"Holla","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0410","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.prostaglandins.2015.03.002","article-title":"Vascular actions of 20-HETE","volume":"120","author":"Hoopes","year":"2015","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0415","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1096\/fj.14-251223","article-title":"miR-21 normalizes vascular smooth muscle proliferation and improves coronary collateral growth in metabolic syndrome","volume":"28","author":"Hutcheson","year":"2014","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0420","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/sj.bjp.0706909","article-title":"RANTES stimulates Ca2+ mobilization and inositol trisphosphate (IP3) formation in cells transfected with G protein-coupled receptor 75","volume":"149","author":"Ignatov","year":"2006","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0425","doi-asserted-by":"crossref","first-page":"478","DOI":"10.2133\/dmpk.20.478","article-title":"Localization of rat cytochrome P450 in various tissues and comparison of arachidonic acid metabolism by rat P450 with that by human P450 orthologs","volume":"20","author":"Imaoka","year":"2005","journal-title":"Drug Metabolism and Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0430","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/01.HYP.22.3.357","article-title":"Elevated renovascular tone in young spontaneously hypertensive rats: Role of cytochrome P450","volume":"22","author":"Imig","year":"1993","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0435","first-page":"H1879","article-title":"Cytochrome P-450 inhibitors alter afferent arteriolar responses to elevations in pressure","volume":"266","author":"Imig","year":"1994","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0440","doi-asserted-by":"crossref","first-page":"F875","DOI":"10.1152\/ajprenal.00364.2009","article-title":"Endothelial-specific CYP4A2 overexpression leads to renal injury and hypertension via increased production of 20-HETE","volume":"297","author":"Inoue","year":"2009","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0445","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1161\/CIRCRESAHA.108.193227","article-title":"Synergistic activation of vascular TRPC6 channel by receptor and mechanical stimulation via phospholipase C\/diacylglycerol and phospholipase A2\/omega-hydroxylase\/20-HETE pathways","volume":"104","author":"Inoue","year":"2009","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0450","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1161\/hy09t1.096249","article-title":"Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis","volume":"38","author":"Intengan","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0455","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1124\/jpet.107.130336","article-title":"20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-kappaB activation and the production of inflammatory cytokines in human endothelial cells","volume":"324","author":"Ishizuka","year":"2008","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0460","first-page":"685","article-title":"Role of androgens in the renal production of 20-hydroxyeicosatetraenoic acid in spontaneously hypertensive rats","volume":"46","author":"Ishizuka","year":"2004","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0465","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.prostaglandins.2012.12.002","article-title":"Elevated level of pro-inflammatory eicosanoids and EPC dysfunction in diabetic patients with cardiac ischemia","volume":"100-101","author":"Issan","year":"2013","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0470","doi-asserted-by":"crossref","first-page":"L369","DOI":"10.1152\/ajplung.00265.2004","article-title":"VEGF-induced relaxation of pulmonary arteries is mediated by endothelial cytochrome P450 hydroxylase","volume":"291","author":"Jacobs","year":"2006","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0475","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/01.RES.0000111523.12842.FC","article-title":"Smooth muscle--specific expression of CYP4A1 induces endothelial sprouting in renal arterial microvessels","volume":"94","author":"Jiang","year":"2004","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0480","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/01.HYP.25.2.166","article-title":"A heme oxygenase product, presumably carbon monoxide, mediates a vasodepressor function in rats","volume":"25","author":"Johnson","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0485","doi-asserted-by":"crossref","first-page":"H528","DOI":"10.1152\/ajpheart.00561.2016","article-title":"Elevated 20-HETE impairs coronary collateral growth in metabolic syndrome via endothelial dysfunction","volume":"312","author":"Joseph","year":"2017","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0490","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1152\/ajprenal.00249.2002","article-title":"Transfection of CYP4A1 cDNA increases vascular reactivity in renal interlobar arteries","volume":"284","author":"Kaide","year":"2003","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0495","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/01.HYP.0000135658.57547.bb","article-title":"Vascular CO counterbalances the sensitizing influence of 20-HETE on agonist-induced vasoconstriction","volume":"44","author":"Kaide","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0500","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1172\/JCI11218","article-title":"Carbon monoxide of vascular origin attenuates the sensitivity of renal arterial vessels to vasoconstrictors","volume":"107","author":"Kaide","year":"2001","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0505","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1124\/dmd.30.9.1022","article-title":"Sexual dimorphism and tissue specificity in the expression of CYP4F forms in Sprague Dawley rats","volume":"30","author":"Kalsotra","year":"2002","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0510","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1161\/01.RES.68.4.1154","article-title":"Inhibitors of cytochrome P450 attenuate the myogenic response of dog renal arcuate arteries","volume":"68","author":"Kauser","year":"1991","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0515","first-page":"H1546","article-title":"Role of cytochrome P-450 4A in oxygen sensing and NO production in rat cremaster resistance arteries","volume":"277","author":"Kerkhof","year":"1999","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0520","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1194\/jlr.M033894","article-title":"Cyclooxygenase-2 dependent metabolism of 20-HETE increases adiposity and adipocyte enlargement in mesenchymal stem cell-derived adipocytes","volume":"54","author":"Kim","year":"2013","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0525","first-page":"R1087","article-title":"Contribution of endogenous carbon monoxide to regulation of diameter in resistance vessels","volume":"276","author":"Kozma","year":"1999","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0530","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s003950200045","article-title":"Opening of ATP-sensitive potassium channels causes generation of free radicals in vascular smooth muscle cells","volume":"97","author":"Krenz","year":"2002","journal-title":"Basic Research in Cardiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0535","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1161\/HYPERTENSIONAHA.107.102921","article-title":"The T8590C polymorphism of CYP4A11 and 20-hydroxyeicosatetraenoic acid in essential hypertension","volume":"51","author":"Laffer","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0540","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/01.HYP.0000051888.91497.47","article-title":"20-HETE and furosemide-induced natriuresis in salt-sensitive essential hypertension","volume":"41","author":"Laffer","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0545","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1161\/01.CIR.0000046269.52392.14","article-title":"Differential regulation of natriuresis by 20-hydroxyeicosatetraenoic Acid in human salt-sensitive versus salt-resistant hypertension","volume":"107","author":"Laffer","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0550","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1089\/104303401750270959","article-title":"Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization","volume":"12","author":"Lai","year":"2001","journal-title":"Human Gene Therapy"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0555","doi-asserted-by":"crossref","first-page":"H1107","DOI":"10.1152\/ajpheart.00961.2015","article-title":"20-HETE-Induced Mitochondrial Superoxide and Inflammatory Phenotype in Vascular Smooth Muscle is Prevented by Glucose-6-Phosphate Dehydrogenase Inhibition","volume":"310","author":"Lakhkar","year":"2016","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0560","unstructured":"Laniado-Schwartzman, M., Falck, J. R., Yadagiri, P., & Escalante, B. (1989). Metabolism of 20-hydroxyeicosatetraenoic acid by cyclooxygenase: formation and identification of novel endothelium-dependent vasoconstrictor metabolites. The Journal of Biological Chemistry, 264, 1165-1162."},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0565","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1074\/jbc.275.6.4118","article-title":"Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11","volume":"275","author":"Lasker","year":"2000","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0570","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.yjmcc.2009.09.018","article-title":"Extracellular matrix alterations in hypertensive vascular remodeling","volume":"48","author":"Lemarie","year":"2010","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0575","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1172\/JCI114686","article-title":"Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats","volume":"86","author":"Levere","year":"1990","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0580","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1016\/S1470-2045(17)30535-1","article-title":"Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms?","volume":"18","author":"Levis","year":"2017","journal-title":"The Lancet Oncology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0585","article-title":"20-Hydroxyeicosatetraenoic acid impairs endothelial insulin signaling by inducing phosphorylation of the insulin receptor substrate-1 at Ser616","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0590","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4238\/2014.January.21.20","article-title":"Association of a CYP4A11 polymorphism and hypertension in the Mongolian and Han populations of China","volume":"13","author":"Liang","year":"2014","journal-title":"Genetics and Molecular Research"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0595","doi-asserted-by":"crossref","first-page":"R248","DOI":"10.1152\/ajpregu.00380.2012","article-title":"Roles played by 20-HETE, angiotensin II and endothelin in mediating the hypertension in aging female spontaneously hypertensive rats","volume":"304","author":"Lima","year":"2013","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0600","first-page":"F806","article-title":"20-Hydroxyeicosatetraenoic acid is formed in response to EGF and is a mitogen in rat proximal tubule","volume":"269","author":"Lin","year":"1995","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0605","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1007\/s00125-013-3022-x","article-title":"The novel chemokine receptor, G-protein-coupled receptor 75, is expressed by islets and is coupled to stimulation of insulin secretion and improved glucose homeostasis","volume":"56","author":"Liu","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0610","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1681\/ASN.2007060713","article-title":"Association of a functional cytochrome P450 4F2 haplotype with urinary 20-HETE and hypertension","volume":"19","author":"Liu","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0615","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.gene.2012.02.029","article-title":"Disturbed ratio of renal 20-HETE\/EETs is involved in androgen-induced hypertension in cytochrome P450 4F2 transgenic mice","volume":"505","author":"Liu","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0620","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/ki.2009.67","article-title":"Overexpression of cytochrome P450 4F2 in mice increases 20-hydroxyeicosatetraenoic acid production and arterial blood pressure","volume":"75","author":"Liu","year":"2009","journal-title":"Kidney International"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0625","doi-asserted-by":"crossref","first-page":"223","DOI":"10.17305\/bjbms.2010.2691","article-title":"Endothelin-1 induced vascular smooth muscle cell proliferation is mediated by cytochrome p-450 arachidonic acid metabolites","volume":"10","author":"Ljuca","year":"2010","journal-title":"Bosnian Journal of Basic Medical Sciences"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0630","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1042\/CS20120483","article-title":"Role of the CYP4A\/20-HETE pathway in vascular dysfunction of the Dahl salt-sensitive rat","volume":"124","author":"Lukaszewicz","year":"2013","journal-title":"Clinical Science (London, England)"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0635","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/micc.12304","article-title":"Role of vascular reactive oxygen species in regulating cytochrome P450-4A enzyme expression in Dahl salt-sensitive rats","volume":"23","author":"Lukaszewicz","year":"2016","journal-title":"Microcirculation"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0640","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/01.RES.72.1.126","article-title":"20-hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries","volume":"72","author":"Ma","year":"1993","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0645","first-page":"R579","article-title":"Altered renal P-450 metabolism of arachidonic acid in Dahl salt-sensitive rats","volume":"267","author":"Ma","year":"1994","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0650","first-page":"G735","article-title":"Characterization of cytochrome P-450-dependent arachidonic acid metabolism in rabbit intestine","volume":"265","author":"Macica","year":"1993","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0655","doi-asserted-by":"crossref","first-page":"F60","DOI":"10.1152\/ajprenal.00265.2001","article-title":"Cytochrome P-450 4A isoform expression and 20-HETE synthesis in renal preglomerular arteries","volume":"283","author":"Marji","year":"2002","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0660","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1097\/01.hjh.0000244944.34546.8e","article-title":"Association of a functional polymorphism in the CYP4A11 gene with systolic blood pressure in survivors of myocardial infarction","volume":"24","author":"Mayer","year":"2006","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0665","doi-asserted-by":"crossref","first-page":"L902","DOI":"10.1152\/ajplung.00278.2007","article-title":"20-HETE increases superoxide production and activates NAPDH oxidase in pulmonary artery endothelial cells","volume":"294","author":"Medhora","year":"2008","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0670","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system","volume":"292","author":"Mehta","year":"2007","journal-title":"American Journal of Physiology. Cell Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0675","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0022-3565(24)37147-2","article-title":"Irreversible inhibition of cytochrome P450 by nitric oxide","volume":"283","author":"Minamiyama","year":"1997","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0680","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1540\/jsmr.41.175","article-title":"Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system","volume":"41","author":"Miyata","year":"2005","journal-title":"Journal of Smooth Muscle Research"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0685","doi-asserted-by":"crossref","first-page":"90S","DOI":"10.1016\/S0895-7061(01)02075-1","article-title":"Abnormal pressure-natriuresis in hypertension: role of cytochrome P450 metabolites of arachidonic acid","volume":"14","author":"Moreno","year":"2001","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0690","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/BJ20061328","article-title":"Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation","volume":"403","author":"Muller","year":"2007","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0695","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/01.HYP.35.1.457","article-title":"Contribution of Ras GTPase\/MAP kinase and cytochrome P450 metabolites to deoxycorticosterone-salt-induced hypertension","volume":"35","author":"Muthalif","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0700","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.HYP.36.4.604","article-title":"Angiotensin II-induced hypertension: contribution of Ras GTPase\/Mitogen-activated protein kinase and cytochrome P450 metabolites","volume":"36","author":"Muthalif","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0705","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0090-6980(01)00112-5","article-title":"Small GTP binding protein Ras contributes to norepinephrine-induced mitogenesis of vascular smooth muscle cells","volume":"65","author":"Muthalif","year":"2001","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0710","doi-asserted-by":"crossref","first-page":"R1055","DOI":"10.1152\/ajpregu.00459.2002","article-title":"Androgen-mediated induction of the kidney arachidonate hydroxylases is associated with the development of hypertension","volume":"284","author":"Nakagawa","year":"2003","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0715","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/17425255.2018.1472237","article-title":"Current knowledge of microRNA-mediated regulation of drug metabolism in humans","volume":"14","author":"Nakano","year":"2018","journal-title":"Expert Opinion on Drug Metabolism & Toxicology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0720","first-page":"R1691","article-title":"Kinetic profile of the rat CYP4A isoforms: arachidonic acid metabolism and isoform-specific inhibitors","volume":"276","author":"Nguyen","year":"1999","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0725","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/abio.2001.5044","article-title":"Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs","volume":"292","author":"Nithipatikom","year":"2001","journal-title":"Analytical Biochemistry"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0730","doi-asserted-by":"crossref","first-page":"H500","DOI":"10.1152\/ajpheart.00918.2005","article-title":"Effects of selective inhibition of cytochrome P-450 omega-hydroxylases and ischemic preconditioning in myocardial protection","volume":"290","author":"Nithipatikom","year":"2006","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0735","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1161\/01.RES.0000146277.62128.6f","article-title":"Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway","volume":"95","author":"Nithipatikom","year":"2004","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0740","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1172\/JCI119279","article-title":"20-Hydroxyeicosa-tetraenoic acid (20 HETE) activates protein kinase C. Role in regulation of rat renal Na+,K+-ATPase","volume":"99","author":"Nowicki","year":"1997","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0745","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/01.RES.87.11.999","article-title":"Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide\/cGMP signaling and endothelial dysfunction","volume":"87","author":"Oelze","year":"2000","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0750","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1681\/ASN.2011121178","article-title":"A look at transactivation of the EGF receptor by angiotensin II","volume":"23","author":"Okada","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0755","first-page":"F591","article-title":"Renal cytochrome P-450-arachidonic acid metabolism: localization and hormonal regulation in SHR","volume":"262","author":"Omata","year":"1992","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0760","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1124\/jpet.113.203844","article-title":"20-Hydroxyeicosatetraenoic acid inhibition attenuates balloon injury-induced neointima formation and vascular remodeling in rat carotid arteries","volume":"346","author":"Orozco","year":"2013","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0765","first-page":"R293","article-title":"Renal oxygenases: differential contribution to vasoconstriction induced by ET-1 and ANG II","volume":"273","author":"Oyekan","year":"1997","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0770","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1172\/JCI6786","article-title":"Renal cytochrome P450 omega-hydroxylase and epoxygenase activity are differentially modified by nitric oxide and sodium chloride","volume":"104","author":"Oyekan","year":"1999","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0775","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10555-010-9264-x","article-title":"Cytochrome P450-derived eicosanoids: the neglected pathway in cancer","volume":"29","author":"Panigrahy","year":"2010","journal-title":"Cancer Metastasis Reviews"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0780","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.prostaglandins.2016.04.004","article-title":"Oxidized HDL is a potent inducer of adipogenesis and causes activation of the Ang-II and 20-HETE systems in human obese females","volume":"123","author":"Peterson","year":"2016","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0785","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0022-3565(24)37530-5","article-title":"Metabolism of arachidonic acid to 20-hydroxy-5,8,11, 14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11","volume":"285","author":"Powell","year":"1998","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0790","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1161\/01.HYP.0000047240.33861.6B","article-title":"20-HETE-induced contraction of small coronary arteries depends on the activation of Rho-kinase","volume":"41","author":"Randriamboavonjy","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0795","doi-asserted-by":"crossref","first-page":"F533","DOI":"10.1152\/ajprenal.00283.2014","article-title":"Mechanism of impaired afferent arteriole myogenic response in Dahl salt-sensitive rats: role of 20-HETE","volume":"307","author":"Ren","year":"2014","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0800","first-page":"F497","article-title":"Parathyroid hormone inhibits Na(+)-K(+)-ATPase through a cytochrome P-450 pathway","volume":"266","author":"Ribeiro","year":"1994","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0805","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1152\/physrev.00021.2001","article-title":"P-450 metabolites of arachidonic acid in the control of cardiovascular function","volume":"82","author":"Roman","year":"2002","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0810","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1161\/01.HYP.21.6.985","article-title":"Clofibrate prevents the development of hypertension in Dahl salt-sensitive rats","volume":"21","author":"Roman","year":"1993","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0815","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0005-2760(95)00238-3","article-title":"Metabolism of arachidonic acid by canine polymorphonuclear leukocytes synthesis of lipoxygenase and omega-oxidized metabolites","volume":"1300","author":"Rosolowsky","year":"1996","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0820","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/01.HYP.38.2.210","article-title":"Human heme oxygenase-1 gene transfer lowers blood pressure and promotes growth in spontaneously hypertensive rats","volume":"38","author":"Sabaawy","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0825","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1126\/science.2492116","article-title":"Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats","volume":"243","author":"Sacerdoti","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0830","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.amjhyper.2004.05.023","article-title":"Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment","volume":"17","author":"Schiffrin","year":"2004","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0835","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.atherosclerosis.2013.01.034","article-title":"Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patients","volume":"227","author":"Schuck","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0840","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/ki.1990.13","article-title":"Cytochrome P450-dependent arachidonic acid metabolism in human kidney","volume":"37","author":"Schwartzman","year":"1990","journal-title":"Kidney International"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0845","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1161\/01.RES.0000148633.93110.24","article-title":"Vanilloid receptor TRPV1, sensory C-fibers, and vascular autoregulation: a novel mechanism involved in myogenic constriction","volume":"95","author":"Scotland","year":"2004","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0850","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pharmthera.2014.05.011","article-title":"Human cytochrome P450 epoxygenases: variability in expression and role in inflammation-related disorders","volume":"144","author":"Shahabi","year":"2014","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0855","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/HYPERTENSIONAHA.107.089599","article-title":"Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension","volume":"50","author":"Singh","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0860","first-page":"29","article-title":"Renal vascular cytochrome P450-derived eicosanoids in androgen-induced hypertension","volume":"60","author":"Singh","year":"2008","journal-title":"Pharmacological Reports"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0865","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/HYPERTENSIONAHA.110.154559","article-title":"CYP4A2-Induced Hypertension Is 20-Hydroxyeicosatetraenoic Acid- and Angiotensin II-Dependent","volume":"56","author":"Sodhi","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0870","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/HYPERTENSIONAHA.110.154559","article-title":"CYP4A2-induced hypertension is 20-hydroxyeicosatetraenoic acid- and angiotensin II-dependent","volume":"56","author":"Sodhi","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0875","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.yjmcc.2018.02.005","article-title":"Elevated 20-HETE in metabolic syndrome regulates arterial stiffness and systolic hypertension via MMP12 activation","volume":"117","author":"Soler","year":"2018","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0880","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026063","article-title":"Role of 20-hydroxyeicosatetraenoic acid in mediating hypertension in response to chronic renal medullary endothelin type B receptor blockade","volume":"6","author":"Speed","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0885","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000099200","article-title":"20-Hydroxyeicosatetraenoic acid (20-HETE) stimulates migration of vascular smooth muscle cells","volume":"19","author":"Stec","year":"2007","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0890","first-page":"522","article-title":"Site specific pharmacological knockout of renal outer medullary P4504A activity produces salt sensitive hypertension in normotensive Lewis rats","volume":"28","author":"Stec","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0895","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/01.HYP.29.1.315","article-title":"Inhibition of renal outer medullary 20-HETE production produces hypertension in Lewis rats","volume":"29","author":"Stec","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0900","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1161\/01.HYP.27.6.1329","article-title":"Cytochrome P4504A activity and salt sensitivity in spontaneously hypertensive rats","volume":"27","author":"Stec","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0905","first-page":"R426","article-title":"Inhibition of renal arachidonic acid omega-hydroxylase activity with ABT reduces blood pressure in the SHR","volume":"275","author":"Su","year":"1998","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0910","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/01.RES.83.11.1069","article-title":"Nitric oxide-20-hydroxyeicosatetraenoic acid interaction in the regulation of K+ channel activity and vascular tone in renal arterioles","volume":"83","author":"Sun","year":"1998","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0915","doi-asserted-by":"crossref","first-page":"H339","DOI":"10.1152\/ajpheart.2000.279.1.H339","article-title":"Role of cGMP versus 20-HETE in the vasodilator response to nitric oxide in rat cerebral arteries","volume":"279","author":"Sun","year":"2000","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0920","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2174\/138920021602150713114159","article-title":"Epigenetic Regulation of Cytochrome P450 Enzymes and Clinical Implication","volume":"16","author":"Tang","year":"2015","journal-title":"Current Drug Metabolism"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0925","doi-asserted-by":"crossref","first-page":"E500","DOI":"10.1152\/ajpendo.00370.2011","article-title":"Enalapril reverses high-fat diet-induced alterations in cytochrome P450-mediated eicosanoid metabolism","volume":"302","author":"Theken","year":"2012","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0930","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1111\/bph.12079","article-title":"Treatment with the cytochrome P450 omega-hydroxylase inhibitor HET0016 attenuates cerebrovascular inflammation, oxidative stress and improves vasomotor function in spontaneously hypertensive rats","volume":"168","author":"Toth","year":"2013","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0935","doi-asserted-by":"crossref","first-page":"H1698","DOI":"10.1152\/ajpheart.00377.2013","article-title":"Role of 20-HETE, TRPC channels, and BKCa in dysregulation of pressure-induced Ca2+ signaling and myogenic constriction of cerebral arteries in aged hypertensive mice","volume":"305","author":"Toth","year":"2013","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0940","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1038\/jcbfm.2013.143","article-title":"Age-related autoregulatory dysfunction and cerebromicrovascular injury in mice with angiotensin II-induced hypertension","volume":"33","author":"Toth","year":"2013","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0945","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/978-3-540-34891-7_35","article-title":"Phospholipase C-coupled receptors and activation of TRPC channels","author":"Trebak","year":"2007","journal-title":"Handbook of Experimental Pharmacology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0950","doi-asserted-by":"crossref","first-page":"H1194","DOI":"10.1152\/ajpheart.00733.2010","article-title":"20-Hydroxyeicosatetraenoic Acid Synthesis Is Increased in Human Neutrophils and Platelets by Angiotensin Ii and Endothelin-1","volume":"300","author":"Tsai","year":"2011","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0955","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.freeradbiomed.2008.10.028","article-title":"20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction","volume":"46","author":"Tsai","year":"2009","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0960","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41467-017-02539-4","article-title":"20-HETE promotes glucose-stimulated insulin secretion in an autocrine manner through FFAR1","volume":"9","author":"Tunaru","year":"2018","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0965","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/SHK.0b013e31816471c6","article-title":"A 20-hydroxyeicosatetraenoic acid agonist, N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine, opposes the fall in blood pressure and vascular reactivity in endotoxin-treated","author":"Tunctan","year":"2008","journal-title":"Rats. Shock"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0970","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/01.RES.0000217283.98806.a6","article-title":"Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus","volume":"98","author":"Wang","year":"2006","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0975","first-page":"F246","article-title":"Contribution of cytochrome P450 4A1 and 4A2 to vascular 20-hydroxyeicosatetraenoic acid synthesis in the rat kidney","volume":"276","author":"Wang","year":"1998","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0980","doi-asserted-by":"crossref","first-page":"F295","DOI":"10.1152\/ajprenal.00065.2003","article-title":"Regulation of renal CYP4A expression and 20-HETE synthesis by nitric oxide in pregnant rats","volume":"285","author":"Wang","year":"2003","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0985","doi-asserted-by":"crossref","first-page":"R255","DOI":"10.1152\/ajpregu.2001.280.1.R255","article-title":"CYP4A1 antisense oligonucleotide reduces mesenteric vascular reactivity and blood pressure in SHR","volume":"280","author":"Wang","year":"2001","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0990","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1440-1681.2011.05509.x","article-title":"Chronic activation of AMP-activated protein kinase prevents 20-hydroxyeicosatetraenoic acid-induced endothelial dysfunction","volume":"38","author":"Ward","year":"2011","journal-title":"Clinical and Experimental Pharmacology & Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb0995","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.diabres.2006.04.001","article-title":"20-Hydroxyeicosatetraenoic acid is not associated with circulating insulin in lean to overweight humans","volume":"74","author":"Ward","year":"2006","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb1000","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.freeradbiomed.2004.12.024","article-title":"Urinary 20-hydroxyeicosatetraenoic acid excretion is associated with oxidative stress in hypertensive subjects","volume":"38","author":"Ward","year":"2005","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb1005","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1161\/01.CIR.0000136808.72912.D9","article-title":"Urinary 20-hydroxyeicosatetraenoic acid is associated with endothelial dysfunction in humans","volume":"110","author":"Ward","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb1010","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1139\/cjpp-2016-0036","article-title":"The cardioprotection of dihydrotanshinone I against myocardial ischemia-reperfusion injury via inhibition of arachidonic acid omega-hydroxylase","volume":"94","author":"Wei","year":"2016","journal-title":"Canadian Journal of Physiology and Pharmacology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb1015","doi-asserted-by":"crossref","first-page":"13868","DOI":"10.1074\/jbc.M111.334896","article-title":"20-Hydroxyeicosatetraenoic acid (20-HETE) is a novel activator of transient receptor potential vanilloid 1 (TRPV1) channel","volume":"287","author":"Wen","year":"2012","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb1020","doi-asserted-by":"crossref","first-page":"R1209","DOI":"10.1152\/ajpregu.00604.2011","article-title":"Role of 20-HETE in the antihypertensive effect of transfer of chromosome 5 from Brown Norway to Dahl salt-sensitive rats","volume":"302","author":"Williams","year":"2012","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb1025","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/FJC.0b013e3181f04b1c","article-title":"20-hydroxyeicosatetraeonic acid: a new target for the treatment of hypertension","volume":"56","author":"Williams","year":"2010","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb1030","doi-asserted-by":"crossref","first-page":"F1764","DOI":"10.1152\/ajprenal.90525.2008","article-title":"Transfer of the CYP4A region of chromosome 5 from Lewis to Dahl S rats attenuates renal injury","volume":"295","author":"Williams","year":"2008","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb1035","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/HYPERTENSIONAHA.110.161570","article-title":"Androgen-dependent hypertension is mediated by 20-hydroxy-5,8,11,14-eicosatetraenoic acid-induced vascular dysfunction: Role of inhibitor of {kappa}B kinase","volume":"57","author":"Wu","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb1040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CRD.0b013e3182961659","article-title":"20-HETE and blood pressure regulation: clinical implications","volume":"22","author":"Wu","year":"2014","journal-title":"Cardiology in Review"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb1045","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1681\/ASN.2012070714","article-title":"Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase","volume":"24","author":"Wu","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb1050","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.prostaglandins.2011.06.006","article-title":"The role of 20-HETE in androgen-mediated hypertension","volume":"96","author":"Wu","year":"2011","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb1055","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1124\/jpet.103.059626","article-title":"Catalytic activity and isoform-specific inhibition of rat cytochrome p450 4F enzymes","volume":"308","author":"Xu","year":"2004","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb1060","doi-asserted-by":"crossref","first-page":"R710","DOI":"10.1152\/ajpregu.00522.2001","article-title":"Antihypertensive effect of mechanism-based inhibition of renal arachidonic acid omega-hydroxylase activity","volume":"283","author":"Xu","year":"2002","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb1065","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1161\/01.HYP.0000168051.04275.ea","article-title":"Contribution of arachidonic acid metabolites derived via cytochrome P4504A to angiotensin II-induced neointimal growth","volume":"45","author":"Yaghini","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb1070","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000317521","article-title":"Role of 20-hydroxyeicosatetraenoic and epoxyeicosatrienoic acids in the regulation of vascular function in a model of hypertension and endothelial dysfunction","volume":"86","author":"Yousif","year":"2010","journal-title":"Pharmacology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb1075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1474-8673.2009.00429.x","article-title":"Cytochrome P450 metabolites of arachidonic acid play a role in the enhanced cardiac dysfunction in diabetic rats following ischaemic reperfusion injury","volume":"29","author":"Yousif","year":"2009","journal-title":"Autonomic & Autacoid Pharmacology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb1080","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1152\/japplphysiol.00247.2002","article-title":"Nitric oxide contributes to 20-HETE-induced relaxation of pulmonary arteries","volume":"93","author":"Yu","year":"2002","journal-title":"Journal of Applied Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb1085","doi-asserted-by":"crossref","first-page":"H1724","DOI":"10.1152\/ajpheart.00699.2001","article-title":"Mechanism of cGMP contribution to the vasodilator response to NO in rat middle cerebral arteries","volume":"282","author":"Yu","year":"2002","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb1090","doi-asserted-by":"crossref","first-page":"H1109","DOI":"10.1152\/ajpheart.00067.2010","article-title":"20-HETE increases NADPH oxidase-derived ROS production and stimulates the L-type Ca2+ channel via a PKC-dependent mechanism in cardiomyocytes","volume":"299","author":"Zeng","year":"2010","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb1095","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s12020-016-1031-5","article-title":"20-HETE attenuates the response of glucose-stimulated insulin secretion through the AKT\/GSK-3beta\/Glut2 pathway","volume":"54","author":"Zhang","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb1100","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1161\/hy1201.096116","article-title":"Modulation by 20-HETE of phenylephrine-induced mesenteric artery contraction in spontaneously hypertensive and Wistar-Kyoto rats","volume":"38","author":"Zhang","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb1105","doi-asserted-by":"crossref","first-page":"H1089","DOI":"10.1152\/ajpheart.00627.2003","article-title":"Transfection of CYP4A1 cDNA decreases diameter and increases responsiveness of gracilis muscle arterioles to constrictor stimuli","volume":"287","author":"Zhang","year":"2004","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb1110","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3109\/00498254.2013.797622","article-title":"Hormonal regulation of Cyp4a isoforms in mouse liver and kidney","volume":"43","author":"Zhang","year":"2013","journal-title":"Xenobiotica"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb1115","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/FJC.0000000000000248","article-title":"20-hydroxyeicosatetraenoic acid is a key mediator of angiotensin II-induced apoptosis in cardiac myocytes","volume":"66","author":"Zhao","year":"2015","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb1120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1124\/jpet.105.095356","article-title":"Induction of renal 20-hydroxyeicosatetraenoic acid by clofibrate attenuates high-fat diet-induced hypertension in rats","volume":"317","author":"Zhou","year":"2006","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb1125","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1152\/japplphysiol.01159.2001","article-title":"R. (2002). CYP4A mRNA, protein, and product in rat lungs: novel localization in vascular endothelium","volume":"93","author":"Zhu","year":"1985","journal-title":"Journal of Applied Physiology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb1130","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1124\/dmd.108.023077","article-title":"Modulation of cytochrome P450 gene expression and arachidonic acid metabolism during isoproterenol-induced cardiac hypertrophy in rats","volume":"36","author":"Zordoky","year":"2008","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb1135","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.taap.2009.09.012","article-title":"Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats","volume":"242","author":"Zordoky","year":"2010","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb1140","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.pharmthera.2009.12.002","article-title":"Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases","volume":"125","author":"Zordoky","year":"2010","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2018.07.004_bb1145","first-page":"F275","article-title":"Inhibition of renal vascular 20-HETE production impairs autoregulation of renal blood flow","volume":"266","author":"Zou","year":"1994","journal-title":"The American Journal of Physiology"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725818301232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725818301232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T23:43:48Z","timestamp":1751759028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725818301232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":229,"alternative-id":["S0163725818301232"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2018.07.004","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"20-HETE in the regulation of vascular and cardiac function","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2018.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}